{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:51:03Z","timestamp":1790358663704,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L212035"],"award-info":[{"award-number":["L212035"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Foundation of Capital Institute of Pediatrics","award":["JCYJ-2023-03"],"award-info":[{"award-number":["JCYJ-2023-03"]}]},{"name":"Beijing Finance Bureau","award":["11000024T000002831273"],"award-info":[{"award-number":["11000024T000002831273"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"DOI":"10.1186\/s13052-025-02058-9","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T10:41:37Z","timestamp":1751971297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel intronic variant in the ASAH1 gene enhances aberrant splicing, causing spinal muscular atrophy with progressive myoclonic epilepsy"],"prefix":"10.1186","volume":"51","author":[{"given":"Jinli","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2959-3754","authenticated-orcid":false,"given":"Yujin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"2058_CR1","first-page":"116","volume":"103","author":"J Jankovic","year":"1978","unstructured":"Jankovic J, Rivera V. Hereditary myoclonus and progressive muscular atrophy: a new syndrome. Trans Am Neurol Assoc. 1978;103:116\u20138.","journal-title":"Trans Am Neurol Assoc"},{"issue":"1","key":"2058_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2012.05.001","volume":"91","author":"J Zhou","year":"2012","unstructured":"Zhou J, Tawk M, Tiziano FD, Veillet J, Bayes M, Nolent F, et al. Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1. Am J Hum Genet. 2012;91(1):5\u201314. https:\/\/doi.org\/10.1016\/j.ajhg.2012.05.001.","journal-title":"Am J Hum Genet."},{"issue":"10","key":"2058_CR3","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/genes15101294","volume":"15","author":"H Nishio","year":"2024","unstructured":"Nishio H, Niba ETE, Saito T, Okamoto K, Lee T, Takeshima Y, et al. Clinical and Genetic Profiles of 5q- and Non-5q-Spinal Muscular Atrophy Diseases in Pediatric Patients. Genes (Basel). 2024;15(10):1294. https:\/\/doi.org\/10.3390\/genes15101294.","journal-title":"Genes (Basel)"},{"issue":"3","key":"2058_CR4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.25122\/jml-2021-0147","volume":"14","author":"M Axente","year":"2021","unstructured":"Axente M, Shelby E-S, Mirea A, Sporea C, Badina M, Padure L, et al. Clinical features and genetics in non-5q spinal muscular atrophy caused by acid ceramidase deficiency. J Med Life. 2021;14(3):424-8. https:\/\/doi.org\/10.25122\/jml-2021-0147.","journal-title":"J Med Life."},{"issue":"19","key":"2058_CR5","doi-asserted-by":"publisher","first-page":"11098","DOI":"10.1074\/jbc.270.19.11098","volume":"270","author":"K Bernardo","year":"1995","unstructured":"Bernardo K, Hurwitz R, Zenk T, Desnick RJ, Ferlinz K, Schuchman EH, et al. Purification, characterization, and biosynthesis of human acid ceramidase. J Biol Chem. 1995;270(19):11098\u2013102. https:\/\/doi.org\/10.1074\/jbc.270.19.11098.","journal-title":"J Biol Chem"},{"issue":"1","key":"2058_CR6","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/s41467-018-03844-2","volume":"9","author":"A Gebai","year":"2018","unstructured":"Gebai A, Gorelik A, Li Z, Illes K, Nagar B. Structural basis for the activation of acid ceramidase. Nat Commun. 2018;9(1):1621. https:\/\/doi.org\/10.1038\/s41467-018-03844-2.","journal-title":"Nat Commun"},{"issue":"1","key":"2058_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13023-018-0845-z","volume":"13","author":"FPS Yu","year":"2018","unstructured":"Yu FPS, Amintas S, Levade T, Medin JA. Acid ceramidase deficiency: farber disease and SMA-PME. Orphanet J Rare Dis. 2018;13(1):121. https:\/\/doi.org\/10.1186\/s13023-018-0845-z.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"2058_CR8","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/humu.24056","volume":"41","author":"SH Elsea","year":"2020","unstructured":"Elsea SH, Solyom A, Martin K, Harmatz P, Mitchell J, Lampe C, et al. ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy. Hum Mutat. 2020;41(9):1469\u201387. https:\/\/doi.org\/10.1002\/humu.24056.","journal-title":"Hum Mutat"},{"issue":"5","key":"2058_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"issue":"3","key":"2058_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting Splicing from Primary Sequence with Deep Learning. Cell. 2019;176(3):535-48.e24. https:\/\/doi.org\/10.1016\/j.cell.2018.12.015.","journal-title":"Cell"},{"key":"2058_CR11","doi-asserted-by":"publisher","unstructured":"Li K, Xiao J, Ling Z, Luo T, Xiong J, Chen Q, et al. Prioritizing de novo potential non-canonical splicing variants in neurodevelopmental disorders. EBioMedicine. 2024;99:104928. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104928.","DOI":"10.1016\/j.ebiom.2023.104928"},{"issue":"2","key":"2058_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/geno.1999.5940","volume":"62","author":"CM Li","year":"1999","unstructured":"Li CM, Park JH, He X, Levy B, Chen F, Arai K, et al. The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression. Genomics. 1999;62(2):223\u201331. https:\/\/doi.org\/10.1006\/geno.1999.5940.","journal-title":"Genomics"},{"issue":"11","key":"2058_CR13","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1038\/ejhg.2016.28","volume":"24","author":"M Filosto","year":"2016","unstructured":"Filosto M, Aureli M, Castellotti B, Rinaldi F, Schiumarini D, Valsecchi M, et al. ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: a clinical, biochemical and molecular study. Eur J Hum Genet. 2016;24(11):1578\u201383. https:\/\/doi.org\/10.1038\/ejhg.2016.28.","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"2058_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.nmd.2014.11.007","volume":"25","author":"BG Gir\u00e1ldez","year":"2015","unstructured":"Gir\u00e1ldez BG, Guerrero-L\u00f3pez R, Ortega-Moreno L, Verd\u00fa A, Carrascosa-Romero MC, Garc\u00eda-Campos \u00d3, et al. Uniparental disomy as a cause of spinal muscular atrophy and progressive myoclonic epilepsy: phenotypic homogeneity due to the homozygous c.125C>T mutation in ASAH1. Neuromuscul Disord. 2015;25(3):222\u20134. https:\/\/doi.org\/10.1016\/j.nmd.2014.11.007.","journal-title":"Neuromuscul Disord."},{"issue":"10","key":"2058_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.neurol.2015.06.002","volume":"171","author":"A B\u00e9hin","year":"2015","unstructured":"B\u00e9hin A, Salort-Campana E, Wahbi K, Richard P, Carlier RY, Carlier P, et al. Myofibrillar myopathies: State of the art, present and future challenges. Rev Neurol (Paris). 2015;171(10):715\u201329. https:\/\/doi.org\/10.1016\/j.neurol.2015.06.002.","journal-title":"Rev Neurol (Paris)"},{"issue":"5","key":"2058_CR16","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/epi.12977","volume":"56","author":"G Rubboli","year":"2015","unstructured":"Rubboli G, Veggiotti P, Pini A, Berardinelli A, Cantalupo G, Bertini E, et al. Spinal muscular atrophy associated with progressive myoclonic epilepsy: A rare condition caused by mutations in ASAH1. Epilepsia. 2015;56(5):692\u20138. https:\/\/doi.org\/10.1111\/epi.12977.","journal-title":"Epilepsia"},{"key":"2058_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clineuro.2017.11.008","volume":"164","author":"EP Yildiz","year":"2018","unstructured":"Yildiz EP, Yesil G, Bektas G, Caliskan M, Tatl\u0131 B, Aydinli N, et al. Spinal muscular atrophy with progressive myoclonic epilepsy linked to mutations in ASAH1. Clin Neurol Neurosurg. 2018;164:47\u20139. https:\/\/doi.org\/10.1016\/j.clineuro.2017.11.008.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"2058_CR18","doi-asserted-by":"publisher","first-page":"6149","DOI":"10.1038\/s41598-017-06604-2","volume":"7","author":"C Cozma","year":"2017","unstructured":"Cozma C, Iura\u0219cu MI, Eichler S, Hovakimyan M, Brandau O, Zielke S, et al. C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease. Sci Rep. 2017;7(1):6149. https:\/\/doi.org\/10.1038\/s41598-017-06604-2.","journal-title":"Sci Rep"},{"key":"2058_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/IMCRJ.S202046","volume":"12","author":"R Shervin Badv","year":"2019","unstructured":"Shervin Badv R, Nilipour Y, Rahimi-Dehgolan S, Rashidi-Nezhad A, Ghahvechi Akbari M. A novel case report of spinal muscular atrophy with progressive myoclonic epilepsy from Iran. Int Med Case Rep J. 2019;12:155\u20139. https:\/\/doi.org\/10.2147\/IMCRJ.S202046.","journal-title":"Int Med Case Rep J"},{"key":"2058_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.seizure.2016.09.007","volume":"42","author":"E Oguz Akarsu","year":"2016","unstructured":"Oguz Akarsu E, Tekturk P, Yapici Z, Tepgec F, Uyguner ZO, Baykan B. Eyelid myoclonic status epilepticus: A rare phenotype in spinal muscular atrophy with progressive myoclonic epilepsy associated with ASAH1 gene mutation. Seizure. 2016;42:49\u201351. https:\/\/doi.org\/10.1016\/j.seizure.2016.09.007.","journal-title":"Seizure"},{"issue":"1","key":"2058_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13052-023-01474-z","volume":"49","author":"A Najafi","year":"2023","unstructured":"Najafi A, Tasharrofi B, Zandsalimi F, Rasulinezhad M, Ghahvechi Akbari M, Zamani G, et al. Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME): three new cases and review of the mutational spectrum. Ital J Pediatr. 2023;49(1):64. https:\/\/doi.org\/10.1186\/s13052-023-01474-z.","journal-title":"Ital J Pediatr"},{"issue":"10","key":"2058_CR22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.nmd.2022.08.002","volume":"32","author":"P Karimzadeh","year":"2022","unstructured":"Karimzadeh P, Najmabadi H, Lochmuller H, Babaee M, Dehdahsi S, Miryounesi M, et al. Five patients with spinal muscular atrophy-progressive myoclonic epilepsy (SMA-PME): a novel pathogenic variant, treatment and review of the literature. Neuromuscul Disord. 2022;32(10):806\u201310. https:\/\/doi.org\/10.1016\/j.nmd.2022.08.002.","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"2058_CR23","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/acn3.51687","volume":"9","author":"MM Lee","year":"2022","unstructured":"Lee MM, McDowell GSV, De Vivo DC, Friedman D, Berkovic SF, Spanou M, et al. The clinical spectrum of SMA-PME and in vitro normalization of its cellular ceramide profile. Ann Clin Transl Neurol. 2022;9(12):1941\u201352. https:\/\/doi.org\/10.1002\/acn3.51687.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"2058_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80(1):155\u201365. https:\/\/doi.org\/10.1016\/0092-8674(95)90460-3.","journal-title":"Cell"},{"issue":"1","key":"2058_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","volume":"8","author":"E Mercuri","year":"2022","unstructured":"Mercuri E, Sumner CJ, Muntoni F, Darras BT, Finkel RS. Spinal muscular atrophy. Nat Rev Dis Primers. 2022;8(1):52. https:\/\/doi.org\/10.1038\/s41572-022-00380-8.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"2058_CR26","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/brain\/awac452","volume":"146","author":"AA Zambon","year":"2023","unstructured":"Zambon AA, Pini V, Bosco L, Falzone YM, Munot P, Muntoni F, et al. Early onset hereditary neuronopathies: an update on non-5q motor neuron diseases. Brain. 2023;146(3):806\u201322. https:\/\/doi.org\/10.1093\/brain\/awac452.","journal-title":"Brain"},{"issue":"9","key":"2058_CR27","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/humu.23560","volume":"39","author":"M Karakaya","year":"2018","unstructured":"Karakaya M, Storbeck M, Strathmann EA, Delle Vedove A, H\u00f6lker I, Altmueller J, et al. Targeted sequencing with expanded gene profile enables high diagnostic yield in non-5q-spinal muscular atrophies. Hum Mutat. 2018;39(9):1284\u201398. https:\/\/doi.org\/10.1002\/humu.23560.","journal-title":"Hum Mutat"},{"issue":"5","key":"2058_CR28","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3390\/ijms21051607","volume":"21","author":"K Kyriakou","year":"2020","unstructured":"Kyriakou K, Lederer CW, Kleanthous M, Drousiotou A, Malekkou A. Acid Ceramidase Depletion Impairs Neuronal Survival and Induces Morphological Defects in Neurites Associated with Altered Gene Transcription and Sphingolipid Content. Int J Mol Sci. 2020;21(5):1607. https:\/\/doi.org\/10.3390\/ijms21051607.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2058_CR29","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/cge.13834","volume":"98","author":"IG Mahmoud","year":"2020","unstructured":"Mahmoud IG, Elmonem MA, Zaki MS, Ramadan A, Al-Menabawy NM, El-Gamal A, et al. ASAH1-related disorders: Description of 15 novel pediatric patients and expansion of the clinical phenotype. Clin Genet. 2020 ;98(6):598-605\u00a0https:\/\/doi.org\/10.1111\/cge.13834.","journal-title":"Clin Genet."},{"issue":"3","key":"2058_CR30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41431-018-0250-z","volume":"27","author":"N van der Beek Ame","year":"2019","unstructured":"Ame van der Beek N, Nelson I, Froissart R, Levade T, Garcia V, Lacene E, et al. A new case of SMA phenotype without epilepsy due to biallelic variants in ASAH1. Eur J Hum Genet. 2019;27(3):337\u20139. https:\/\/doi.org\/10.1038\/s41431-018-0250-z.","journal-title":"Eur J Hum Genet"},{"key":"2058_CR31","unstructured":"Dyment DA, Bennett SAL, Medin JA, Levade T. ASAH1-related disorders. GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. 2018:1993\u20132025."},{"issue":"9","key":"2058_CR32","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.bbadis.2016.05.001","volume":"1862","author":"EH Schuchman","year":"2016","unstructured":"Schuchman EH. Acid ceramidase and the treatment of ceramide diseases: The expanding role of enzyme replacement therapy. Biochim Biophys Acta. 2016;1862(9):1459\u201371. https:\/\/doi.org\/10.1016\/j.bbadis.2016.05.001.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"2058_CR33","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1016\/j.ymthe.2024.08.004","volume":"32","author":"J Rybova","year":"2024","unstructured":"Rybova J, Sundararajan T, Kuchar L, Dlugi TA, Ruzicka P, McKillop WM, et al. Hematopoietic stem cell transplantation leads to biochemical and functional correction in two mouse models of acid ceramidase deficiency. Mol Ther. 2024;32(10):3402\u201321. https:\/\/doi.org\/10.1016\/j.ymthe.2024.08.004.","journal-title":"Mol Ther"},{"issue":"3\u20134","key":"2058_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41434-022-00359-w","volume":"30","author":"H Zhang","year":"2023","unstructured":"Zhang H, Nagree MS, Liu H, Pan X, Medin JA, Lipinski DM. rAAV-mediated over-expression of acid ceramidase prevents retinopathy in a mouse model of Farber lipogranulomatosis. Gene Ther. 2023;30(3\u20134):297\u2013308. https:\/\/doi.org\/10.1038\/s41434-022-00359-w.","journal-title":"Gene Ther"},{"issue":"1","key":"2058_CR35","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41467-021-21371-5","volume":"12","author":"A Khan","year":"2021","unstructured":"Khan A, Barber DL, Huang J, Rupar CA, Rip JW, Auray-Blais C, et al. Lentivirus-mediated gene therapy for Fabry disease. Nat Commun. 2021;12(1):1178. https:\/\/doi.org\/10.1038\/s41467-021-21371-5.","journal-title":"Nat Commun"},{"issue":"7971","key":"2058_CR36","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41586-023-06277-0","volume":"619","author":"J Kim","year":"2023","unstructured":"Kim J, Woo S, de Gusmao CM, Zhao B, Chin DH, DiDonato RL, et al. A framework for individualized splice-switching oligonucleotide therapy. Nature. 2023;619(7971):828\u201336. https:\/\/doi.org\/10.1038\/s41586-023-06277-0.","journal-title":"Nature"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02058-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-02058-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02058-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T10:41:39Z","timestamp":1751971299000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-02058-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2058"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-02058-9","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from his parents, and the study was approved by the Ethics Committee of Capital Institute of Pediatrics. All methods of this study were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to publish has been received from all the families.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No authors declared any potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}